Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panelnews2021-12-01T00:23:13+00:00December 1st, 2021|The New York Times|
Concerns Grow Over Safety of Aduhelm After Death of Patient Who Got the Drugnews2021-11-22T16:00:09+00:00November 22nd, 2021|The New York Times|
F.D.A. Authorizes Coronavirus Booster Shots for All Adultsnews2021-11-19T21:45:01+00:00November 19th, 2021|The New York Times|
F.D.A. Authorizes Covid Booster Shots for All Adultsnews2021-11-19T21:44:59+00:00November 19th, 2021|The New York Times|
U.S. to Buy Enough of Pfizer’s Covid Antiviral Pills for 10 Million Peoplenews2021-11-17T02:47:01+00:00November 17th, 2021|The New York Times|
F.D.A. Plans to Authorize Pfizer Boosters for All Adults This Weeknews2021-11-17T01:17:59+00:00November 17th, 2021|The New York Times|
Pfizer Asks F.D.A. to Authorize Covid Pill For High-Risk Unvaccinated Peoplenews2021-11-17T00:40:29+00:00November 17th, 2021|The New York Times|
Biden Chooses Robert Califf to Lead F.D.A., Despite Drug Industry Tiesnews2021-11-12T21:31:34+00:00November 12th, 2021|The New York Times|
Pfizer Says Its Antiviral Pill Is Highly Effective in Treating Covidnews2021-11-05T19:13:46+00:00November 5th, 2021|The New York Times|
What Happens Next as F.D.A., C.D.C. Weigh Covid Shots for Childrennews2021-10-26T12:40:51+00:00October 26th, 2021|The New York Times|
